Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)
1 clinical trials · Condition
◉ Watch Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)
| Record | Firm | Date |
|---|---|---|
| ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC) (NCT02319005) | Alnylam Pharmaceuticals | 2014-12-01 |
Track Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC) automatically
Every clearance here is in the API, with alerts when new ones post.